Division News

  • Gene Therapy 2.0

    By Emily Mullin

    Scientists have solved fundamental problems that were holding back cures for rare hereditary disorders. Next we’ll see if the same approach can take on cancer, heart disease, and other common illnesses.

  • Gene-Editing Gets A Go-Ahead

    Guest host Anthony Brooks

    Growing support for human gene-editing. We’ll look at new breakthroughs and the ethical debate

    Those in the know call CRISPR “one of the greatest life science inventions ever.” It has sparked a headline-grabbing patent fight worth billions of dollars. But more importantly, it has revolutionized the ability to make precise changes to human DNA, opening the door to revolutionary ways to treat disease – but also to ethical questions about engineered designer babies. This hour On Point, the brave new world of human DNA editing and CRISPR.

  • Stanford scientists describe stem-cell and gene-therapy advances in scientific symposium

    By Erin Digitale

    Using stem cells and gene therapy to treat or cure disease may still sound like science fiction, but a scientific meeting here last week emphasized all the fronts on which it is moving closer and closer to fact.

  • Chan Zuckerberg Biohub Names Investigators, Builds Collaborative Culture

    By Allison Proffitt

    The Chan Zuckerberg Biohub has named its first cohort of 47 investigators from the University of California, Berkeley, Stanford University and the University of California, San Francisco.

  • Faculty members receive grants from state stem cell agency


    The grants to Stanford researchers target stem cell-based therapies for autoimmune disorders, liver disease and cystic fibrosis.

    Three researchers from the School of Medicine have been awarded grants by the governing board of the California Institute for Regenerative Medicine to promote the discovery of potential stem cell-based therapies.

  • “Lifting the hood” on rare immune diseases can help patients get the treatment they need

    By Erin Digitale

    “One clinical picture can have so many different underlying causes,” said pediatric hematologist Katja Weinacht, MD, PhD. When a patient’s immune system is attacking the body’s own red blood cells, for instance, non-specific treatments like steroids may not be enough to put immune disease into remission, Weinacht explained. And the treatments’ side effects can exact a heavy price, especially from young patients.